• US$150

• 252 designs

• 92 designers

---

Brief de Design de Logo

The Company was formed as an early development stage pharmaceutical company focused on monetizing the therapeutic potential of the small molecule compound TTT-3002 with sole-in-class activity for Alzheimer’s Disease (AD) and a variety of related neurodegenerative orphan indications, and best-in-class target activity for Acute Myeloid Leukemia (AML). This has some of the top major researchers at world renowned hospitals like the Mayo Clinic, and Johns Hopkins University involved in the research. This logo will be seen and recognized around the world. I am attaching below some basic logos that have been used before on papers, but, there has yet to be a design that will become the logo for the company. We will choose one of these to represent it.

Secteur / Type d'entité

It Company

Texte du logo

TauTaTis

---

Fichiers